$165 Million is the total value of Pettee Investors, Inc.'s 144 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 21.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| JPM | Sell | JPMorgan Chase | $10,579,000 | +11.9% | 98,926 | -0.1% | 6.42% | +5.1% |
| XOM | Sell | Exxon Mobil | $5,795,000 | +1.6% | 69,277 | -0.4% | 3.52% | -4.5% |
| BMY | Sell | Bristol-Myers Squibb | $3,600,000 | -4.0% | 58,747 | -0.2% | 2.18% | -9.8% |
| GE | Sell | General Electric | $2,009,000 | -31.2% | 115,114 | -4.7% | 1.22% | -35.4% |
| IBM | Sell | International Business Machine | $1,798,000 | +5.3% | 11,720 | -0.4% | 1.09% | -1.1% |
| MKC | Sell | McCormick | $1,610,000 | -1.0% | 15,798 | -0.3% | 0.98% | -7.0% |
| CELG | Sell | Celgene | $1,313,000 | -29.2% | 12,586 | -1.0% | 0.80% | -33.5% |
| SLB | Sell | Schlumberger | $1,075,000 | -8.9% | 15,945 | -5.7% | 0.65% | -14.4% |
| MON | Sell | Monsanto | $864,000 | -3.8% | 7,392 | -1.3% | 0.52% | -9.7% |
| ESRX | Sell | Express Scripts | $634,000 | +16.1% | 8,491 | -1.5% | 0.38% | +9.1% |
| SPB | Sell | Spectrum Brands Holdings | $466,000 | -24.2% | 4,146 | -28.6% | 0.28% | -28.7% |
| RE | Sell | Everest RE Group | $411,000 | -38.8% | 1,857 | -36.9% | 0.25% | -42.6% |
| LVNTA | Sell | Liberty Ventures | $401,000 | -41.6% | 7,401 | -38.0% | 0.24% | -45.3% |
| URI | Sell | United Rentals | $378,000 | +22.3% | 2,200 | -1.1% | 0.23% | +14.5% |
| F | Sell | Ford Motor | $130,000 | -8.5% | 10,400 | -12.6% | 0.08% | -14.1% |
| CVS | Exit | CVS/Caremark | $0 | – | -2,625 | -100.0% | -0.14% | – |
| RLGY | Exit | Realogy Holdings | $0 | – | -14,775 | -100.0% | -0.32% | – |
| PBH | Exit | Prestige Brands Holdings | $0 | – | -11,218 | -100.0% | -0.36% | – |
| ACC | Exit | American Campus Comm. | $0 | – | -13,434 | -100.0% | -0.38% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-02-06
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Johnson & Johnson | 40 | Q3 2023 | 17.3% |
| JPMorgan Chase | 40 | Q3 2023 | 8.0% |
| Exxon Mobil | 40 | Q3 2023 | 9.3% |
| Pfizer | 40 | Q3 2023 | 6.0% |
| Procter & Gamble | 40 | Q3 2023 | 4.8% |
| Bristol-Myers Squibb | 40 | Q3 2023 | 4.1% |
| Nestle ADR | 40 | Q3 2023 | 3.4% |
| PepsiCo | 40 | Q3 2023 | 3.4% |
| Intel | 40 | Q3 2023 | 3.3% |
| Disney | 40 | Q3 2023 | 3.1% |
View Pettee Investors, Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-07 |
| 13F-HR | 2023-10-20 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-05 |
| 13F-HR | 2023-01-25 |
| 13F-HR | 2022-11-09 |
| 13F-HR | 2022-07-25 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-11 |
| 13F-HR | 2021-11-02 |
View Pettee Investors, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.